Verastem, Inc. (VSTM)
8.41
-0.97
(-10.34%)
USD |
NASDAQ |
Nov 06, 16:00
8.31
-0.10
(-1.19%)
Pre-Market: 20:00
Verastem Cash from Operations (Quarterly) : -43.91M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.91M |
| March 31, 2026 | -52.12M |
| December 31, 2025 | -29.95M |
| September 30, 2025 | -36.22M |
| June 30, 2025 | -32.66M |
| March 31, 2025 | -38.68M |
| December 31, 2024 | -25.10M |
| September 30, 2024 | -23.80M |
| June 30, 2024 | -27.57M |
| March 31, 2024 | -28.31M |
| December 31, 2023 | -29.68M |
| September 30, 2023 | -16.59M |
| June 30, 2023 | -19.90M |
| March 31, 2023 | -20.29M |
| December 31, 2022 | -16.62M |
| September 30, 2022 | -15.08M |
| June 30, 2022 | -12.69M |
| March 31, 2022 | -19.28M |
| December 31, 2021 | -9.933M |
| September 30, 2021 | -10.83M |
| June 30, 2021 | -13.42M |
| March 31, 2021 | -19.32M |
| December 31, 2020 | -21.70M |
| September 30, 2020 | 42.98M |
| June 30, 2020 | -22.55M |
| Date | Value |
|---|---|
| March 31, 2020 | -34.00M |
| December 31, 2019 | -37.66M |
| September 30, 2019 | -27.85M |
| June 30, 2019 | -34.67M |
| March 31, 2019 | -38.78M |
| December 31, 2018 | -19.19M |
| September 30, 2018 | -22.56M |
| June 30, 2018 | -10.31M |
| March 31, 2018 | -22.45M |
| December 31, 2017 | -20.33M |
| September 30, 2017 | -11.85M |
| June 30, 2017 | -14.48M |
| March 31, 2017 | -10.65M |
| December 31, 2016 | -5.952M |
| September 30, 2016 | -6.019M |
| June 30, 2016 | -6.691M |
| March 31, 2016 | -10.82M |
| December 31, 2015 | -10.20M |
| September 30, 2015 | -11.61M |
| June 30, 2015 | -12.02M |
| March 31, 2015 | -11.73M |
| December 31, 2014 | -9.655M |
| September 30, 2014 | -9.255M |
| June 30, 2014 | -8.716M |
| March 31, 2014 | -9.276M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cytokinetics, Inc. | -124.02M |
| Inovio Pharmaceuticals, Inc. | -18.05M |
| Rigel Pharmaceuticals, Inc. | 30.65M |
| United Therapeutics Corp. | 306.50M |
| SELLAS Life Sciences Group, Inc. | -7.588M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 16.25M |
| Cash from Financing (Quarterly) | -1.539M |
| Free Cash Flow | -171.82M |
| Free Cash Flow Per Share (Quarterly) | -0.4386 |
| Free Cash Flow to Equity (Quarterly) | -42.76M |
| Free Cash Flow to Firm (Quarterly) | -43.54M |
| Free Cash Flow Yield | -23.02% |